The 2023 data for the global blood grouping reagents market shows Spain leading with a per capita value of $2.14, followed by the UK ($1.64) and Italy ($1.52). Greece and Croatia also demonstrate substantial figures at $1.35 and $1.01, respectively. At the lower end, Brazil has the smallest value per capita at $0.16. These figures indicate a varied market landscape, with significant differences in market penetration and potential healthcare expenditure amongst these countries.
Future trends to observe include potential market expansion in emerging economies such as Brazil and Thailand, driven by increased healthcare investments and demand for blood diagnostics. Additionally, advancements in medical technologies and a growing focus on precision medicine might further influence market dynamics.
Top countries in Blood Grouping Reagents Market Size Value Per Capita by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | |
|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data |
| 2 | 2 United Kingdom | 1.64 | 2023 | View data |
| 3 | 3 Italy | 1.52 | 2023 | View data |
| 4 | 4 Greece | 1.35 | 2023 | View data |
| 5 | 5 Croatia | 1.01 | 2023 | View data |
| 6 | 6 Portugal | 0.9 | 2023 | View data |
| 7 | 7 Hungary | 0.84 | 2023 | View data |
| 8 | 8 Belgium | 0.65 | 2023 | View data |
| 9 | 9 Poland | 0.59 | 2023 | View data |
| 10 | 10 Lithuania | 0.48 | 2023 | View data |
